Autophagy is an intracellular pathway that contributes to the degradation and recycling of unfolded proteins. Based on the knowledge that autophagy affects glycogen metabolism and that "1-antitrypsin (AAT) deficiency is associated with an autophagic response in the liver, we hypothesized that the conformational abnormalities of the Z-AAT protein interfere with hepatocyte glycogen storage and/or metabolism. Compared to wild type mice (WT), the Z-AAT mice had lower liver glycogen stores (p<0.001) and abnormal activities of glycogen-related enzymes, including acid "-glucosidase (p<0.05) and the total glycogen synthase (p<0.05). As metabolic consequences, PiZ mice demonstrated lower blood glucose levels (p<0.05), lower body weights (p<0.001), and lower fat pad weights (p<0.001) compared to WT. Following the stress of fasting or partial hepatectomy, PiZ mice had further reduced liver glycogen and lower blood glucose levels (both p<0.05 compared WT). Finally, PiZ mice exhibited decreased survival following partial hepatectomy (p<0.01compared to WT), but was normalized with postoperative dextrose supplementation. In conclusion, these observations are consistent with the general concept that abnormal protein conformation and degradation affects other cellular functions suggesting that diseases in the liver might benefit from metabolic compensation if glycogen metabolism is affected.
Introduction
"1-antitrypsin (AAT), a 52 kDa 394 amino acid single chain glycoprotein produced primarily by liver hepatocytes, functions as the major circulating inhibitor of neutrophil elastase (1, 2) . The common Z-AAT mutation (glu342lys, referred to as "PiZ", for "protease inhibitor Z") results in a systemic deficiency of AAT (1, 2) . The consequences of this single amino acid substitution are profound, including emphysema secondary to deficiency of lung anti-elastase protection and cirrhosis resulting from the toxic effects of the accumulation of the abnormal Z-AAT molecules in the liver (1) (2) (3) (4) (5) .
The liver disease associated with AAT deficiency is a prototype of conformational diseases, disorders due to misfolding of proteins, with consequent aberrant intermolecular protein aggregation (2) (3) (4) (5) (6) (7) . In contrast to the normal M-type AAT which rapidly transits through the endoplasmic reticulum (ER) and is efficiently secreted by hepatocytes, the Z-AAT form of AAT accumulates in the hepatocyte ER secondary to abnormal folding of the Z molecule, resulting in interaction between the reactive center loop of one Z-AAT molecule with the $-pleated sheet of a second, causing loop-sheet polymerization and consequent accumulation of Z-AAT in the ER (3, 4, (8) (9) (10) .
The understanding of the mechanism of the liver disease associated with AAT deficiency has been significantly advanced by studies of the "PiZ" mouse, a transgenic murine model of the Z form of AAT by Woo and colleagues (11, 12) and Perlmutter and colleagues (13) (14) (15) (16) (17) (18) (19) . Recent studies demonstrated that Z-AAT accumulation in the ER exhibits a specific cellular response, including initiation of the endoplasmic reticulum stress response, activation of proapoptotic caspases, and autophagy as one of the major features (5, 16, 18, (18) (19) (20) (21) . Autophagy is thought to be a specific cellular response activated by ER accumulation of Z-AAT, whereby cytosol and -2 -intracellular organelles, are first sequestered from the cytoplasm into autophagosomes, allowing them to be degraded subsequently within lysosomes (22, 23) . These observations support the general hypothesis that accumulation of misfolded proteins is associated with dysfunction of diverse cellular pathways (3, 4, 24, 25) . Based on these concepts and the knowledge that among other changes, autophagy interferes with glycogen storage and/or metabolism (26) (27) (28) (29) , we hypothesized that the conformational abnormalities resulting in Z-AAT accumulation and consequent cellular response interfere with hepatocyte glycogen storage and/or metabolism, similar to other models of autophagy (26) (27) (28) (29) . To assess this hypothesis, we evaluated a variety of glycogen-related metabolic parameters in PiZ transgenic mice. The data reveal that PiZ mice have lower liver glycogen stores, lower blood glucose levels, lower body weights and lower fat pad weights than wild type mice and abnormal activities of glycogen-related enzymes, including acid "-glucosidase and glycogen synthase. Strikingly, the PiZ mice have reduced survival following partial hepatectomy but show comparable survival to wild type mice with dextrose supplementation following surgery. Together, these data add to the general concept of cellular metabolic dysfunction resulting from the conformational abnormalities of proteins raise the interesting possibility that patients with AAT deficiency might benefit from metabolic compensation of the dysfunction in glycogen metabolism in the liver.
Methods

Experimental Animal
Transgenic PiZ mice with the human Z-AAT gene on a C57Bl/6 background (kindly provided by D. Perlmutter, University of Pittsburgh School of Medicine, Pittsburgh, PA), were maintained on 12 hr dark/light cycles and provided with water and standard rodent diet ad libitum. Littermates were separated by gender at age of 4 wk. Gender-matched wild type -3 -C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME or Taconic, Inc., Germantown, NY) were used as controls. To confirm expression of human AAT in PiZ mice, blood was collected by tail vein puncture and allowed to clot for 1 hr at 23°C followed by centrifugation at 10,000 x g for 5 min to collect serum. Quantitative assessment of human Z-AAT in mouse serum was performed using an AAT ELISA kit (ALPCO Diagnostic, Windham, NH) with a standard curve generated using a purified human AAT standard (courtesy of M. Brantly, University of Florida, Gainsville, FL) (30) .
The high expressing PiZ mice were identified by high Z-AAT level in the serum (2.3 ± 0.5 :M) compared to low expressing mice that had an average Z-AAT level of 5.2 ± 4.9 nM. Z-AAT was not detected in wild type mice. High Z-AAT expressing mice were selected for extensive characterization and comparison to wild type mice as described below. Low Z-AAT expressing mice received a selective characterization as detailed in the Supplemental Data.
Briefly, histological analysis showed that low Z-AAT expressing mice had few, if any, PASpositive globules in the liver; both histological and biochemical data demonstrated a reduced level of hepatocyte glycogen; and low Z-AAT expressing mice exhibited good viability following partial hepatectomy (Supplemental Table I ; Supplemental Figure 1 ). In summary, low Z-AAT expressing mice presented an intermediate phenotype, therefore high Z-AAT expressing mice were selected for further analysis in this study.
Tissue Glycogen Stores
To evaluate glycogen stores, liver was harvested from randomly fed wild type (n=8) and PiZ mice (n=8) under 2% isoflurane anesthesia (Baxter, Deerfield, IL). Tissue was fixed overnight at 4°C in PBS with 4% paraformaldehyde (Electron Microscopy Sciences, Fort Washington, PA), and then transferred to 80% ethanol followed by processing through a graded series of alcohols and xylene prior to paraffin embedding. Sections (5 :m) were deparaffinized and stained with hematoxylin and eosin (H&E) to show gross morphology of the tissue. To evaluate the glycogen content of the tissue, the method of Lillie and Greco was used (31).
Glycogen content was indicated by the comparative periodic-acid Schiff (PAS) staining with or without prior amylase treatment (Histoserv, Germantown, MD).
To evaluate quantitative glycogen levels in liver tissue and left gastrocnemius muscle, tissues were harvested from randomly fed wild type (n=6) and PiZ mice (n=6) as described above, frozen quickly in liquid nitrogen and stored at -80°C until further assessment. The method of Roehring and Allred (32) were used which described a quantitative evaluation of glycogen levels in muscle and liver tissue using a direct enzymatic procedure. The test is based on incubation of liver homogenate with amyloglucosidase, which degrades glycogen to glucose, and the glucose was then determined enzymatically by the use of glucose oxidase and peroxidase (33) . Frozen tissue samples were cut in small pieces with a razor blade and weighed. Samples were homogenized (Tissue-Tearor, Biospec Products, Bartlesville, OK) in 100 mM sodium acetate, pH 5.0, for 15 sec, transferred to a boiling water bath for 5 min and homogenized again for 15 sec as reported (31) . The samples were then incubated overnight at 22°C on a shaker in 100:l of H 2 O (background) or H 2 O with amyloglucosidase (50 units/ml, amyloglucosidase from Aspergillus niger, Sigma, St. Louis, MO). After a brief centrifugation (12.000 x g, 5 min, 4°C) to remove nuclei and unbroken tissue, the concentration of glucose liberated by the amyloglucosidase was determined using a commercial glucose oxidase -kit (Sigma), whereby glucose is oxidizised to gluconic acid and hydrogen peroxide with glucose oxidase. Tissue glycogen levels were calculated by determining the difference between the glucose level with and without amyloglucosidase incubation and normalized to wet tissue weight. Purified glycogen -5 - (type IX from bovine liver; Sigma) was used to generate a standard curve (0.063 to1.0 mg) to ensure that measured glucose levels were within the linear range of detection of the assay.
Glycogen Metabolism
Key enzymes involved in glycogen metabolism were evaluated in liver tissue of randomly fed mice. After harvesting liver tissue as described above, tissue was frozen rapidly in liquid nitrogen and stored at -80°C until further processing.
Glycogen synthase activity (n=3 each group) was analyzed using a radioactive method initially described by Thomas et al (32) with minor modification as reported by DePaoli-Roach and colleagues (34) . The method quantifies the incorporation of [ Glycogen phosphorylase activity (n=4 each group) was assayed in the direction of glycogen breakdown using spectrophotometric determination of the rate of NADPH formation in crude liver extracts using a method coupled to phosphoglucomutase and glucose-6-phosphate dehydrogenase as described by Maddaiah et al (36) . Liver tissue (50 to100 mg) was placed into 500 :l of cold sample buffer [4°C, 100 mM glycylglycine, 100 mM sodium flouride, 1mM EDTA, pH 6.8] and homogenized. The homogenate was cleared with two centrifugations at 8000 x g, 2°C, 15 min as described above. The protein concentration of the final supernatant was adjusted to 2 mg/ml. For the activity assay, 250 :l phosphate assay buffer (51 mM potassium phosphate, 0.2% glycogen type III from rabbit liver, 1.4 mM MgCl, 0.1 mM EDTA, 0.44 mM nicotinamide adenine dinucleotide phosphate (NADP+), 0.0003% "-D-glucose 1,6-diphosphate, 1 U glucose-6-phosphate dehydrogenase, and 1 U phosphoglucomutase, pH 6.8) was added to wells of a Costar 96 well UV plate (Corning Technology, Corning, NY) in the presence or absence of 1.6 mM adenosine 5'-monophosphate and the reaction was initiated by adding 10 :l -7 -of sample. Glycogen phosphorylase activity was determined spectrophotometrically at 340 nm at intervals of 2 min for a period of 60 min at 37°C. A purified phosphorylase A from rabbit muscle (Sigma) was used for each experiment to generate a standard curve (0.03 to 2.0 U/ml). The activity of glycogen phosphorylase A was plotted as the average rate of reaction and was linear under these conditions throughout the 20 min reaction. Heat denatured samples (5 min, 99°C) were used as negative controls (data not shown).
Acid "-glucosidase activity (n=5 each group) was measured fluorometrically with the artifical substrate 4-methylumbelliferyl-"-D-glucopyranoside (4MUG, Sigma, St. Louis, MO) which was initially established by Salafsky and Nadler (37) to quantify the activity of acid "-glucosidase in liver tissue and fibroblasts for the diagnosis of Pompe's disease. We followed the modified protocol of Bijvoet et al (38) , who measured the activity of acid "-glucosidase at a suboptimal pH of 3.6 to reduce the interference of neutral glucosidase isoenzymes. Liver tissue (50 to 100 mg) was placed into 250 :l 4°C ice cold phosphate-buffered saline pH 7.4, homogenized, and centrifuged twice (8000 x g, 2°C, 15 min). Supernatant protein concentration was adjusted to 1 mg protein/ml. Tissue homogenates (30 :l) were added to a 30 :l substrate solution containing 5 mM 4MUG in 0.2 M sodium citrate buffer, pH 3.6 at 37°C. The incubation was stopped after precisely 1 hr by addition of 600 :l of 0.2 M glycine buffer, pH 10.8. Liberated 4-methylumbelliferone was measured (excitation 365 nm, emission 445 nm) with a Spectramax M5 UV meter (Molecular Devices, Sunnyvale, CA) in black wall 96 well UV plates (Apogent, Hudson, NH). Purified "-glucosidase from rice (dilution between 0.78 U/ml and 50 U/ml, Sigma) was used as a standard for each experiment. Heat denatured samples (5 min, 99°C) were used as negative controls (not shown).
Blood Glucose Levels
Blood glucose levels of randomly fed wild type and PiZ mice were measured at a consistent time of day (4 to 5 PM) with a glucometer (Precision Xtra, Medisense, Abott Laboratories, CA). Blood glucose levels were evaluated in an age-matched group (n=10 wild type, n=14 PiZ; evaluation of all mice aged between 15 and 18 wk at one single time point) and in a body-weight matched group (n=6 wild type, n=11 PiZ; evaluation of all mice with a body weight between 22.0 and 24.9 mg). Values for single animals at single time points are reported as the mean of three independent determinations.
Body Weight and Fat Pads
Body weights of wild type and PiZ mice were measured with a closed scale (Ohaus, Pine Brook, NJ). Mice fed ad libitum were weighed in three age groups: 10 to 11 wk (n=10 wild type, n=5 PiZ), 19 to 20 wk (n=10 wild type, n=9 PiZ), and 24 to 25 wk (n=10 wild type, n=11 PiZ).
Epigonadal fat pads were removed en bloc after careful removal of bladder and testis under 2% isoflurane anesthesia in 29 to 30 wk old randomly fed mice (n=5 both groups) as described by Plum et al (39) .
Stress by Partial Hepatectomy and Fasting
Two strategies were used to stress the liver of the PiZ mice, partial hepatectomy and fasting as initially established by the groups of Perlmutter and Teckman (16, 18) . Partial hepatectomies were performed between 4 and 7 PM using randomly fed wild type and PiZ mice in the age between 16 and 21 wk under 2% isoflurane anesthesia. To avoid a bias during surgery, mice of different groups underwent hepatectomies in random order. The liver was mobilized through a median laparotomy and the anterior right and left lobes together with the posterior left lobe (in total corresponding to a two-thirds partial hepatectomy) were resected en bloc after -9 - tightening the ligature over the vascular hilia at hepatic base. The liver lobes were immediately frozen in liquid nitrogen after removal and stored at -80°C. After checking the abdominal cavity for residual bleeding, the abdomen was closed in two layers with 3.0 silk ties. The animals were maintained in a heated room until recovery from anesthesia and were supplied with water and standard diet ad libitum. Resected liver lobes were used for morphologic and biochemical evaluation of tissue glycogen as described above. Twenty to 24 hr after partial hepatectomy, remaining liver lobes (right middle, right posterior) were resected for morphologic and biochemical evaluation of tissue glycogen (n=9 wild type, n=5 PiZ) under isoflurane anesthesia.
One cohort of PiZ mice were treated as described above, but in addition mice received a single intraperitoneal administration of 500 :l saline (n=8) or 10% dextrose (n=8) immediately after surgery. Survival rates were followed over 7 days in comparison to wild type mice treated with saline (n=8).
To stress mice by fasting, chow was withheld from age matched wild type and PiZ mice for 18 hr (fasts initiated between 7 and 9 PM). On the next day, the blood glucose levels were measured (n=15 wild type, n=9 PiZ) with a glucometer as described above. To evaluate liver glycogen level, liver tissue (n=10 wild type, n=6 PiZ) was harvested and tissue glycogen was quantified as described above.
Statistics
All data are reported as mean ± standard error. A two-tailed Student's t test with unequal variance was used to compare conditions with p values <0.05 indicative of a significant difference. Survival was assessed using Kaplan-Meier analysis.
Results
Glycogen Stores in Liver and Muscle
The gross morphology of the livers of the PiZ mice appeared similar to that of wild type mice. Histological examination revealed an intact hepatic architecture in wild type and PiZ mice ( Figure 1A, B) , except spherical cytoplasmic inclusions, also referred to as "globules", within the hepatocytes of the PiZ mice ( Figure 1D , F) similar to other reports (18) . The globules were positive (bright magenta) when stained with the periodic acid Schiff (PAS) stain ( Figure 1D ) and this was resistant to amylase treatment ( Figure 1F ). In contrast, the liver of wild type mice did not contain PAS-positive inclusions ( Figure 1C, E) . The liver parenchyma in wild type mice changed from PAS-positive ( Figure 1C ) to PAS-negative with amylase treatment (Figure 1E Figure 1G ). To evaluate the tissue specificity of this observation, glycogen levels were quantified in muscle tissue of randomly fed mice as a negative control. Wild type and PiZ mice contained comparable levels of glycogen (p>0.9; Figure 1H ).
Glycogen Metabolism
Glycogen metabolism is influenced by the supply of glucose 1-phosphate, activation of -11 - glycogen synthetase and the rates of glycogen catabolism by glycogen phosphorylase and acid "-glucosidase (40) . To evaluate the hypothesis that glycogen metabolism was disturbed in PiZ mice, each of these enzymes was assessed in randomly fed mice. The glycogen synthase activity measured in the absence of glucose-6-phosphate reflects the activity of the active glycogen synthase, which was unchanged in WT and PiZ mice p>0.4; Figure 2B ). In the presence of glucose-6-phosphate, inactive glycogen synthase is converted to active glycogen synthase, making this condition an indicator of total synthase protein. PiZ mice exhibited a 3-fold reduction in total glycogen synthase activity compared to WT mice (77% decrease compared to the mean level in wild type controls, p<0.01; Figure 2B ), suggesting a limited capacity of glycogen synthase activity in total in PiZ mice. Under normal physiologic conditions, glycogen phosphorylase is the major catabolic enzyme in glycogen (40) . Neither active glycogen phosphorylase levels (measured in the absence of supplemental AMP) nor total glycogen phosphorylase levels (measured in the presence of supplemental AMP) were changed in PiZ mice relative to wild type mice (p>0.5; Figure 2C ). It is known that activity of acid "-glucosidase in lysosomes of hepatocytes is contributes to the glycogen degradation in the liver (26) (27) (28) (29) . The liver of PiZ mice exhibited a mild but significant elevation in enzyme activity relative to wild type mice (46 % increase compared to mean wild type level, p<0.05; Figure 1D ).
Blood Glucose Levels
Based on the knowledge that hepatic glycogen stores are important to maintain plasma glucose levels (40), we evaluated blood glucose levels. In age-matched 14 to 18 wk old randomly fed mice, PiZ mice revealed a mild but significant decrease in blood glucose levels compared to wild type mice (13% decrease from mean wild type level, p<0.05; Figure 3A ).
However, PiZ mice were significantly lighter than wild type mice at this time point (24% -12 - decrease from mean wild type weight, p<0.01; data not shown). To exclude the possibility that blood glucose levels varied as a function of weight, blood glucose levels were determined in body weight-matched mice. When matched by weight, the PiZ mice still exhibited lower blood glucose levels compared to wild type mice (17% decrease from mean wild type level, p<0.01; Figure 3B ). To verify lower body weight of PiZ mice, we evaluated body weights in different age groups (Table I ). The weights of wild type and PiZ mice were indistinguishable in 10 to 11 wk old mice (p>0.8). In 19 to 20 wk old mice, PiZ mice were significantly lighter than wild type mice (10% decrease from mean wild type weight, p<0.001). The difference was greater in the oldest group of 24 to 25 wk old mice (16% decrease from mean wild type weight, p<0.0001).
Epigonadal fat pad weight, an indicator of total body fat in mice (39) , was reduced in the PiZ mice, with 29 to 30 wk old PiZ mice having almost half the amount of fat pads standardized to body weight compared to wild type mice (48% decrease from mean wild type weight, p<0.001; Table I ).
Glycogen Stores in Liver and Blood Glucose Levels After Fasting
Liver glycogen plays an important role in blood glucose homeostasis, especially during periods of stress (40) . Given the decreased ability of PiZ mice to store glycogen, we hypothesized that the response of PiZ mice to physiological stress would be impaired. As one model of stress requiring utilization of liver glycogen, wild type and PiZ mice were fasted for 18 hr, and liver tissue was collected for analysis.
H&E staining of fasted wild type and PiZ mice showed normal hepatic architecture without signs of hepatocyte injury ( Figure 4A, B) . PAS staining showed a significant depletion of glycogen in wild type mice reminiscent of the pattern observed in post-hepatectomy livers, with scattered cells retaining PAS-positive cytoplasms ( Figure 4C, arrows) . After fasting, PiZ -13 -mice livers maintained brightly stained, PAS-positive inclusions ( Figure 4D ). Quantitative analysis of glycogen levels in liver showed that both fasted wild type (76% decrease from the mean observed in randomly fed mice) and PiZ mice (89% decrease from the mean observed in randomly fed mice) had decreased glycogen levels compared to randomly fed mice (p<0.05, both comparisons, data not shown). Amylase treatment did not make a significant change in the overall appearance of the PAS stain reflecting the depletion of glycogen in the liver tissues ( Figure 4E, F) . Comparison of fasting wild type to PiZ mice demonstrated that the wild type mice still had higher amounts of glycogen stored in the liver (92% decrease from the mean wild type value, p<0.001; Figure 4G ). To assess glucose homeostasis in wild type and PiZ mice after fasting, blood glucose levels were measured. Randomly fed PiZ mice had lower blood glucose levels compared to wild type mice after 18 h fasting (27% decrease from the mean wild type value, p<0.01; Figure 4H ).
Glycogen Stores in Liver and Blood Glucose Levels After Partial Hepatectomy
In a second stress model, wild type and PiZ mice were underwent a two-thirds partial hepatectomy and after 24 hr, livers were assessed morphologically and biochemically for glycogen content.
A general morphological assessment 24 hr after partial hepatectomy showed the presence of vacuoles in hepatocytes of both wild type and PiZ mice suggesting liver injury ( Figure 5A, B) .
PAS staining suggested a significant depletion of glycogen in wild type mice, with scattered cells retaining PAS-positive cytoplasms ( Figure 5C, arrows) . The livers of the PiZ mice after partial hepatectomy continued to harbor the brightly stained, PAS-positive inclusions, likely reflecting the aggregated Z-AAT ( Figure 5D ). The relative depletion of glycogen was reflected in the failure of amylase treatment to change the PAS staining pattern (Figure 5E, F) . -14 - Quantification of glycogen levels in both wild type and PiZ mice verified lower glycogen stores in PiZ mice following partial hepatectomy (95% decrease from wild type level, p<0.001; Figure   5G ). Blood glucose levels were assessed in wild type and PiZ mice after partial hepatectomy.
Randomly fed PiZ mice had lower blood glucose levels compared to wild type mice after partial hepatectomy (95% decrease from wild type level, p<0.05; Figure 5H ).
Survival After Partial Hepatectomy
Following partial hepatectomy, PiZ mice were observed to be lethargic and prone to tremors, consistent with the concept that the PiZ mice may exhibit severe physiological consequences of stress resulting from low glycogen and low blood glucose levels prior to surgery. To test this hypothesis, the survival of mice was observed following partial hepatectomy. Three groups of mice were studied: (1) wild type mice receiving saline immediately following surgery; (2) PiZ mice receiving saline immediately following surgery; and (3) PiZ mice receiving saline supplemented with 10% dextrose immediately following surgery. Survival in wild type mice was high (88%) with the only death in this group occurring <24 hr after surgery, likely secondary to trauma rather than metabolism ( Figure 6 ). Consistent with the observed dysfunction in glycogen stores and metabolism in the PiZ mice, the PiZ mice had a markedly decreased survival following partial hepatectomy with deaths occurring <48 hr after surgery (p<0.01 compared to wild type mice receiving saline). Of interest, for PiZ mice with low blood serum Z-AAT levels, survival after partial hepatectomy was not significantly different from wild type mice, an observation consistent with the mild morphological phenotype in the livers of this group (see Supplemental Figure 2 ). In contrast, when the PiZ mice received dextrose supplementation, they had a striking improvement in survival (63%, p<0.01 compared to PiZ mice receiving saline), supporting the conclusion that deaths among PiZ mice that -15 - received saline were linked to inability to maintain blood glucose levels.
Discussion
The presence of unfolded proteins in cells can induce autophagy, an intracellular pathway that can apparently contribute to the degradation and recycling of unfolded proteins. Based on the knowledge that the PiZ murine model of AAT deficiency mimics the conformational abnormalities of the Z protein in the hepatocyte and evokes autophagy (17, 41, 42) , and that autophagy interferes with the glycogen metabolism (26-29), we hypothesized that the conformational abnormalities of the Z-AAT protein in the PiZ mouse induce dysfunction in hepatocyte metabolic pathways involving glycogen. The data in the current study are consistent with this hypothesis. The liver glycogen levels are significantly lower in the PiZ mice, and PiZ mice demonstrated abnormal activities of glycogen-related enzymes including glycogen synthase and acid "-glucosidase. As metabolic consequences, the PiZ mice have lower blood glucose levels, as are the body weights than wild type controls and a disproportionate loss of body fat.
When the PiZ mice are stressed with partial hepatectomy or fasting, their liver glycogen and blood glucose levels are lower than those of similarly stressed wild type mice. Strikingly, the PiZ mice have a higher mortality following partial hepatectomy, but consistent with the hypothesis of liver glycogen metabolism dysfunction, the PiZ mice have normal survival if they are supplemented with parenteral dextrose following surgery. Together, these observations are consistent with the concept that the conformational abnormalities of the Z protein evoked subtle changes in cellular metabolism that had systemic implications, suggesting that diseases might benefit from metabolic compensation of the dysfunction in glycogen metabolism in the liver.
The data in this report point to several possible changes in glycogen metabolism that might have contributed to glycogen degradation. The observed loss of glycogen in PiZ mice -16 - might have been caused by decreased glycogen synthesis, since PiZ mice exhibited a 3-fold reduction in glycogen synthase (as measured by total tissue enzyme activity) compared to wild type mice possibly resulting in a limited capacity for glycogen synthesis in PiZ mice. However, when assaying only the active pool of glycogen synthase as opposed to the total pool of the enzyme, no difference between PiZ mice and wild type mice was observed. The decreased glycogen content could also have resulted from an increase of acid-" glucosidase activity, however, the magnitude of that increase (<2-fold) was modest. Interestingly, there are reports in the literature suggesting that autophagy might be connected to an induction of acid-" glucosidase activity leading to a glycogen hydrolyzation in autophagosome (26, 28, 29, 43, 44 (4, 19, 37) . Recently, it has been demonstrated that glucose administration improved survival of caveolin 1-knockout mice after partial hepatectomy (45) .
The caveolin-1 knockout mice have defects in lipid homeostasis and cell proliferation after -17 - partial hepatectomy (45) . In addition to the observation here that accumulation of body fat in PiZ mice was reduced, prior reports have noted differences between fat accumulation in the livers of PiZ mice and wild type mice following physiologic stress (18) . Therefore potential links between lipid metabolism and glycogen regulation in PiZ mice may be warranted.
As part of the present study, the PiZ mice were stressed to determine if the deficit in glycogen storage might have significant consequences for the mice. Two stress models were employed, both of which have previously been applied to PiZ mice with reports of outcomes that differ from wild type mice. Teckman et al. (18) showed that PiZ mice had a significantly decreased tolerance for prolonged fasting compared with wild type mice, and Rudnick et al. (16) reported an increased mortality after partial hepatectomy compared to wild type mice. Although the prior study demonstrated a slightly higher survival after partial hepatectomy in PiZ mice compared to the present study, the two studies agree that PiZ mice are at greater risk of mortality compared to wild type mice after partial hepatectomy. In both studies, PiZ mice after surgery became lethargic, had tremors, and died within 48 hr. Both fasting and partial hepatectomy resulted in decreased liver glycogen and decreased blood glucose levels in both wild type and PiZ mice. Reasoning that the severe consequences resulted from a suboptimal glycogen supply, blood sugar was artificially raised by dextrose supplementation after surgery and the PiZ mice had a markedly improved post-surgical clinical course after partial hepatectomy, thus confirming the fact that PiZ mice have a significant alteration of their carbohydrate metabolism.
The hepatotoxicity associated with AAT deficiency is thought to result from a gain-of-toxic function mechanism (41) . In humans, variable expressivity of hepatotoxicity is observed (6,7), leading to the suggestion that genetic modifiers and/or environmental variables may play a significant role in the development of liver disease (41) . Based on the data presented here, an -18 - appreciation of the hepatocyte metabolic changes induced by Z-AAT might be one factor in understanding how a subset of AAT-deficient patients could be pre-disposed to liver disease. At this point, AAT deficiency is not connected to any glycogen disorder. However, the classic phenotype of a patient with AAT deficiency, which includes a thin, relatively underweight individual, has always been attributed to the extra exertion during breathing for these individuals. This study raises the interesting possibility that a metabolic shift in the liver may contribute to the phenotype. If this were to be true, the changes that one might expect to observe in humans would be far less dramatic than the PiZ mouse phenotype reported here since PiZ mice express multiple copies of the mutant Z-AAT while AAT deficiency patients carry only two copies of mutant AAT. 
